Samuel E Gandy, MD, PhD Email Samuel Gandy
- PROFESSOR | Neurology
- PROFESSOR | Psychiatry
- Alzheimer's Disease
- Hospital Affiliation
- The Mount Sinai Hospital
- Center for Cognitive Health 212-241-7076 212-241-7076
Sam Gandy, MD, PhD, is Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center in New York City, and Chairman Emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association. Dr. Gandy is an international expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. In 1989, Gandy and his team discovered the first drugs that could lower formation of amyloid. Dr. Gandy has written more than 250 original papers, chapters, and reviews on this topic. Dr. Gandy has received continuous NIH funding for his research on amyloid metabolism since 1986.
Dr. Gandy is studying new methods for using blood and brain imaging biomarkers to diagnose chronic traumatic encephalopathy (CTE) during life in athletes retired from collision sports and in former warfighters exposed to improvised explosive device blast injuries on the battlefield. Dr. Gandy is also testing new classes of drugs aimed at relieving brain trauma-related neuropsychiatric syndromes such as post-traumatic stress disorder (PTSD).
Dr. Gandy is a member of the Faculty of 1000 Biology and serves as a consulting editor for The Journal of Clinical Investigation. He also serves on the editorial advisory boards for the journals Public Library of Science-Medicine (PLoSM), Neurodegenerative Diseases, and Current Alzheimer Research. He is associate editor of the journals Molecular Neurodegeneration and Alzheimer Disease and Associated Disorders. From 1996-2006, Dr Gandy was Director of the Cold Spring Harbor Laboratories/Wellcome Trust Annual Summer Course on the Neurobiology of Human Neurological Disorders. In 2000, he became chief organizer for the Cold Spring Harbor Laboratories Bi-Annual Winter Biotechnology Conference on Therapeutic Opportunities in Neurodegenerative Diseases and continues in that role until 2010.
Dr. Gandy has appeared numerous times on television and in print, including:
- Alzheimer's Disease
- Cognitive Impairment (Post Head Injury)
- Cognitive or Memory Impairment / Dementia
- Confused Memory
- Confusion (Post Head Injury)
- Frontal Lobe Dementia
- Head Injury
- Huntington's Disease
- Lewy Body Disease
- Lumbar Puncture
- Memory Disorder
- Multiple System Atrophy
- Paraneoplastic Syndrome
- Transient Global Amnesia
- Vascular Dementia
- Visual Neglect
Alzheimer's Disease, Biochemistry, Biomedical Sciences, Biophysics, Brain, Brain Imaging, Cell Biology, Cognitive Neurology, Cognitive Neuroscience, Drug Design and Discovery, Genetics, Genomics, Hippocampus, Hormones, IGF-1 Receptor, Immunology, Induced pluripotent stem cells, Inflammation, Interferon, Intracellular Transport, Lipid Signaling, Lysosomes/endosome, Macrophage, Mass Spectrometry, Memory, Metabolism, Microglia, Neuro-degeneration/protection, Neurobiology, Neurology, Neuronal Regeneration, Neuroscience, Neurotoxicology, Neurotransmitters, Personalized Medicine, Pharmacogenomics, Pharmacology, Phosphorylation, Positron Emission Tomography, Prefrontal Cortex, Proteases, Protein Complexes, Protein Degradation, Protein Folding, Protein Kinases, Protein Phosphatases, Protein Structure/Function, Protein Trafficking & Sorting, Proteomics, Psychiatry, Receptors, Regeneration, Stem Cells, Synapses, Synaptic Plasticity, Synaptogenesis, Systems Biology, T Cells, Trafficking, Viruses and Virology
Multi-Disciplinary Training Area
MD, Medical University of South Carolina
MD, PhD, Medical University of South Carolina
Internship, Internal Medicine
Columbia University College of Physicians & Surgeons
New York Hospital Cornell University Med Ctr
Arthur Cherkin Memorial Award in Geriatric Medicine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Gandy did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.